FAKTOR RESIKO DAN KARAKTERISTIK INFANTIL HEMANGIOMA DI RSUD DR. SOETOMO TAHUN 2015-2019
Understanding Risk Factors and Characteristics of Infantile Hemangioma: Insights from RSUD Dr. Soetomo
Introduction
Infantile hemangioma, a common vascular tumor in infants, presents unique challenges in diagnosis and treatment. At RSUD Dr. Soetomo, our comprehensive analysis of cases from 2015 to 2019 has provided critical insights into the risk factors and characteristics associated with this condition. This blog post highlights our findings and their implications for improving patient care.
Key Risk Factors Identified
- Maternal Age:
- Impact: Our study indicates that maternal age plays a significant role in the likelihood of developing infantile hemangioma. Older maternal age is associated with an increased risk of this condition in infants.
- Family History:
- Impact: A positive family history of hemangioma is a notable risk factor. Children with relatives who have had hemangiomas are at a higher risk of developing the condition themselves.
- Preconception Medication:
- Impact: The use of certain medications before conception has been found to influence the development of infantile hemangioma. Understanding this association can help in identifying at-risk pregnancies and planning appropriate care.
Implications for Care
- Improved Diagnosis:
- Recognizing these risk factors allows for earlier and more accurate diagnosis of infantile hemangioma. Early detection is crucial for effective management and treatment.
- Enhanced Monitoring:
- With knowledge of these risk factors, healthcare providers can implement better monitoring strategies for infants who are at higher risk. This enables timely intervention and reduces the risk of complications.
- Personalized Treatment:
- Understanding the underlying risk factors facilitates more personalized care plans. Providers can tailor treatments to the specific needs of each child, improving overall outcomes.
Our findings emphasize the importance of considering these risk factors in the management of infantile hemangioma. As we continue to advance our understanding of this condition, our goal is to refine diagnostic and treatment approaches to enhance patient care.
The insights gained from our analysis of infantile hemangioma at RSUD Dr. Soetomo provide valuable information for improving the diagnosis, monitoring, and treatment of this condition. By addressing key risk factors such as maternal age, family history, and preconception medication, we can offer more effective and personalized care to affected infants.
